P

PricePrime Medicine

PRME

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

Historical stock price chart and annual return over the past years

-90%

2 years

% Total

PRME
-53%

2 years

Annual Return

PRME